問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-09-01 - 2022-11-30
Condition/Disease
Test Drug
Participate Sites12Sites
Recruiting10Sites
Terminated2Sites
2020-02-29 - 2022-11-30
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NC-6004
Participate Sites4Sites
Recruiting4Sites
2014-07-15 - 2021-03-30
NA
ARN-509; softgel capsule
Participate Sites5Sites
Recruiting5Sites
2023-10-01 - 2030-12-31
Biliary Tract Cancer
Rilvegostomig
Participate Sites8Sites
Recruiting8Sites
2023-02-15 - 2025-06-30
Chronic Hepatitis B
GS-2829GS-6779
Participate Sites10Sites
2023-04-12 - 2028-04-12
Participate Sites1Sites
Recruiting1Sites
2018-01-01 - 2022-01-31
Moderate to Severe Chronic Kidney Disease (stage 3B to 4)
ELIXCYTE
Participate Sites3Sites
Recruiting3Sites
Division of Nephrology
全部
